Bevacizumab intravítreo como tratamiento de maculopatías miópicas neovasculares Intravitreal bevacizumab for neovascular myopic maculopathy. METH [Internet]. 2017 Jul. 25 [cited 2024 Aug. 9];2(2):p. 55-58. Available from: https://revistas.bibdigital.uccor.edu.ar/index.php/method/article/view/1357